Jennison Associates
CALA

Jennison Associates’s Calithera Biosciences, Inc CALA Stock Holding History

Jennison Associates’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-3,621
Closed -$456K – 721
2018
Q1 		$456K Sell
3,621
-274
-7% -$42.7K ﹤0.01% 613
2017
Q4 		$651K Buy
+3,895
New +$997K ﹤0.01% 614
2015
Q2 		– Sell
-8,242
Closed -$2.71M – 776
2015
Q1 		$2.71M Sell
8,242
-28,658
-78% -$10.2M ﹤0.01% 575
2014
Q4 		$14.9M Buy
+36,900
New +$9.64M 0.01% 464

Other funds holding CALA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

Jennison Associates's CALA Position: Q2 2018 in Review

Jennison Associates sold out of Calithera Biosciences, Inc (CALA) in Q2 2018, closing a stake of 3,621 shares — an estimated $456K sold.

Jennison Associates first reported a position in CALA in Q4 2014 and held it in 4 quarters. The position peaked at $14.9M in Q4 2014. 90 funds tracked by Wall St. Rank hold CALA as of Q2 2018.

  • Jennison Associates reported no remaining Calithera Biosciences, Inc position as of Q2 2018 after selling out during the quarter.
  • Jennison Associates sold 3,621 Calithera Biosciences, Inc shares in Q2 2018, an estimated $456K.
  • Jennison Associates first reported a position in Calithera Biosciences, Inc in Q4 2014 and held it in 4 quarters.
  • Jennison Associates's Calithera Biosciences, Inc position peaked at $14.9M in Q4 2014.
  • 90 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2018.

Based on Jennison Associates's 13F filing for Q2 2018, filed 2 Aug 2018.